ACTIMMUNE (ri)
NULOJIX (cc)
HYMPAVZI (ah)
XENOPOZYME (rg)
100

How is Actimmune administered? ROA


SUBCUTANEOUSLY (SQ) 


100

Through which route is Nulojix administered?

              

Intravenously

100

The minimum age required to use hympavzi

12 years old

100

What is the route of administration that is used for Xenopozyme therapy 

What is intravenous infusion

200

What is Actimmune used to treat?

Used to reduce the frequency and severity of chronic granulomatous disease and for delaying time for disease progression in severe, malignant osteopetrosis 

200

Nulojix is indicated for prophylaxis of organ rejections in adults receiving this transplant.

Kidney

200

If on maintenance dosing and more than ___ days have passed since last infusion, a loading dose is required before resuming maintenance dosing

A. 1 day

B. 13 days

C. 24 days

200

Xenopozyme is primarily used to treat this rare, inherited condition, which affects the body’s ability to break down certain fats in cells


What is acid sphingomyelinase deficiency (ASMD)?

300

What are common side effects after the admin of actimmune and how can they be minimized? 


Flu-like symptoms (fever, headache, chills, myalgia, fatigue). 

Premedicate with acetaminophen and give at bedtime.

300

The frequency of a nulojix maintenance dose

Every 4 weeks

300

What is the lab produced protein that the Hympavzi drug is classified as, due to its ability to bind specifically to certain proteins in the body

Monoclonal antibody

300

The approval of Xenopozyme was supported by clinical trial results that demonstrated its effectiveness in improving this organ's function in patients with ASMD (which organ)


What is lung function?

400

What is the recommended frequency/intervals for labs (CBC, BMP, urinalysis) for patient on ACTIMMUNE therapy? 

Prior to the beginning of treatment and at 3 month intervals during treatment. 

400

Only patients that are seropositive for this virus should receive nulojix.

Epstein Barr Virus/ EBV

400

What is the protein that naturally prevents blood clots from forming by inhibiting the coagulation cascade. (This is the main target of Hympavzi)

Tissue factor pathway inhibitor (TFPI)

400

The pivotal clinical trials for Xenopozyme demonstrated improvement in the ability of patients to do this, which is often a measure of physical health


What is the ability to walk or motor skills?

500

What bacteria is Actimmune genetically engineered from?

A. E. COLI 


B. SALMONELLA


C. MRSA


D. LISTERIA

500

The frequency of Nulojix infusions during the initial treatment phase

Day of transplant, 4 days, 2 weeks, 4 weeks, 8 weeks, 12 weeks after transplant

500

What is the bioavailability of Hympavzi after subcutaneous administration?

A. 55%

B. 99%

C. 71%

500

Like other enzyme replacement therapies, Xenopozyme helps to replace an enzyme that the body cannot produce in sufficient amounts due to a genetic mutation, which leads to this process


What is lysosomal storage disorder

M
e
n
u